Michigan loses $3M on drug manufacturing try; API maker Croda buys a biotech firm;

> The University of Michigan expects to lose $120,000 next year, on top of $3.028 million this year, invested in an effort to get a Department of Defense contract to manufacture products at a former Pfizer ($PFE) site. Story

> A trade association in Africa says if countries there would invest more in research and development they would get better manufacturing as a side benefit. Article

> Chemicalmaker Croda has paid £5.9 million ($9.2 million) to buy the Italian biotech company Istituto di Ricerche Biotecnologiche and will merge it with its Sederma skin care business. Release

> Growth of 13% the unit that includes API sales at Albemarle helped buffer the overall 8% fall in revenue in the second quarter. Story

And Finally... The SME Pharma Industries Confederation (SPIC) in India is pushing the government even the tax burden for all contract manufacturing organizations, saying that those in tax-free zones are getting 70% of all contracts. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.